This announcement appears as a matter of record only

BioSafe Medical
Technologies

received $18,000,000 in
multiple financing rounds for
working capital and development from
 

Whitman-Hart, et.al.

FOCUS Regional Managing Partner
William S. Lear assisted in the negotiations as the representative of
BioSafe Medical Technologies.